Table 1.
Characteristics of survivor cohort.
| Total in Cohort N=2930 | ||
|---|---|---|
| N (%) | ||
| Age at diagnosis | 0–9 | 1875 (64.0) |
| 10–14 | 601 (20.5) | |
| 15–20 | 485 (16.6) | |
| Age at study | 21–25 | 302 (10.3) |
| 26–30 | 692 (23.6) | |
| 31–35 | 658 (22.5) | |
| 36–40 | 601 (20.5) | |
| >40 | 655 (22.4) | |
| Diagnosis | Leukemia | 1149 (39.2) |
| Hodgkin Lymphoma | 348 (11.9) | |
| Kidney Tumors | 344(11.7) | |
| Bone Tumors | 311 (10.6) | |
| Neuroblastoma | 254 (8.7) | |
| Soft Tissue Sarcomas | 224 (7.6) | |
| CNS Tumors | 157 (5.4) | |
| Non Hodgkin Lymphoma | 143 (4.9) | |
| Treatment exposure | Alkylating Agent Only | 552 (18.8) |
| Ovarian RT Only | 792 (27.0) | |
| Alkylating Agent and Ovarian RT | 804 27.4) | |
| Unilateral Oophorectomy | 62 (2.1) | |
| Stem Cell Transplant | 17 (0.5) | |
| Smoking History | Yes | 786 (26.8) |
| No | 1741 (59.4) | |
| Unknown | 403 (13.8) | |
| Body Mass Index | Above 30 | 555 (18.9) |
| between 25 and 29.9 | 542 (18.5) | |
| Under 24.9 | 1117 (38.1) | |
| Unknown | 313 (10.7) | |